Literature DB >> 29960635

Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in micezzm321990with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Qing Ye, Xiaolei Yuan, Jie Zhou, Canxing Yuan, Xuming Yang.   

Abstract

OBJECTIVE: To investigate the regulatory mechanism of the c-Jun N-terminal protein kinase (JNK) signaling pathway in substantia nigra (SN) dopaminergic neurons inflammation and apoptosis, and the neuroprotective effect of Zishenpingchan granules in mice with Parkinson's disease (PD) induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
METHODS: PD model mice were established by intraperitoneally injecting MPTP. Sixty mice were divided into a model group, Traditional Chinese Medicine (TCM) group and control group. The mice of the TCM group were administered Zishenpingchan granules 7 days before PD induction. Seven days after PD induction, we examined locomotor activity, and performed the rotarod test and swimming test, to evaluate limb movement function. Furthermore, we used immunohistochemistry and western blotting to examine the expression of tyrosine hydroxylase (TH), cyclooxygenase-2 (Cox-2), caspase-3 and p-JNK. The terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) method was used to examine neuron apoptosis in the SN.
RESULTS: Compared with the control group, the mean score of locomotor activity, rotarod test and swimming test was significantly lower in the model group (P < 0.05); the TH-positive neuron expression was significantly decreased in the SN pars compacta (SNpc); the protein expression levels of Cox-2, caspase-3 and p-JNK was obviously increased; and the number of TUNEL-positive neurons in the SN was increased (P < 0.01). Compared with the model group, the mean score of neurobehavioral tests in the TCM group was obviously higher, the loss of TH-positive neurons ignificantly decreased, the protein expression levels of Cox-2, caspase-3 and p-JNK obviously decreased, and the number of TUNEL- positive neurons in the SN clearly decreased (P < 0.01).
CONCLUSION: The JNK pathway plays an important role in the regulation of inflammation and apoptosis in nigral cells in PD mice. TCM can suppress the over-activation of the JNK pathway in the SN, and alleviate the inflammatory response in nigral cells and dopaminergic neuron apoptosis in PD mice.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29960635     DOI: 10.1016/s0254-6272(17)30051-1

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  4 in total

1.  Traditional Chinese medicine syndrome differentiation and treatment by stages of Parkinson's disease: study protocol for a multicentre, randomized, double-blind, placebo-controlled clinical trial.

Authors:  Yuqing Hu; Sichun Gu; Xiaolei Yuan; Hui Li; Canxing Yuan; Qing Ye
Journal:  Chin Med       Date:  2022-06-13       Impact factor: 4.546

2.  Zishenpingchan granules for the treatment of Parkinson's disease: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Qing Ye; Xiao-Lei Yuan; Can-Xing Yuan; Hong-Zhi Zhang; Xu-Ming Yang
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

3.  Pingchan Granule for Motor Symptoms and Non-Motor Symptoms of Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Si-Chun Gu; Qing Ye; Chang-De Wang; Shao-Rong Zhao; Jie Zhou; Chen Gao; Yu Zhang; Zhen-Guo Liu; Can-Xing Yuan
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

4.  Zishen pingchan granules combined with pramipexole in the improvement of depressive symptoms in Parkinson's disease: a prospective, multicenter, randomized, double-blind, controlled clinical study.

Authors:  Houxu Ning; Hao Zhou; Jingru Ren; Gaiyan Zhou; Ning Yang; Zhenfu Wang; Canxing Yuan; Zuojun Tian; Juping Chen; Lihua Shen; Huifen Zheng; Yang Zhao; Haidong Wang; Weiguo Liu; Zhenguo Liu
Journal:  J Transl Med       Date:  2022-08-12       Impact factor: 8.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.